41 – 50 of 137
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Compliance with National and International Guidelines in the Treatment of Nonmotor Symptoms in Late-Stage Parkinson's Disease
- Contribution to journal › Article
-
Mark
Healthcare resource utilization and device-aided therapy discussions with eligible patients across the Parkinson's disease continuum : Revelations from the MANAGE-PD validation cohort
Fernandez, Hubert H. ; Odin, Per LU
; Standaert, David G.
; Henriksen, Tove
; Jimenez-shahed, Joohi
; Metz, Sharon
; Alobaidi, Ali
; Yan, Connie H.
; Kukreja, Pavnit
and Parra, Juan Carlos
, et al.
(2023)
In Parkinsonism and Related Disorders
116.
- Contribution to journal › Article
-
Mark
Homocysteine, vitamin B metabolites, dopamine-substituting compounds, and symptomatology in Parkinson’s disease : clinical and therapeutic considerations
Phokaewvarangkul, Onanong ; Bhidayasiri, Roongroj ; Garcia-Ruiz, Pedro ; Odin, Per LU
; Riederer, Peter
and Müller, Thomas
(2023)
In Journal of Neural Transmission
130(11).
p.1451-1462
- Contribution to journal › Scientific review
-
Mark
Application of single wrist-wearable accelerometry for objective motor diary assessment in fluctuating Parkinson's disease
Löhle, Matthias ; Timpka, Jonathan LU ; Bremer, Alexander ; Khodakarami, Hamid ; Gandor, Florin ; Horne, Malcom ; Ebersbach, Georg ; Odin, Per LU
and Storch, Alexander
(2023)
In npj Digital Medicine
6(1).
- Contribution to journal › Article
-
Mark
A Paradigm Shift in the Management of Patients with Parkinson's Disease
Tsamis, Konstantinos I. ; Odin, Per LU
; Antonini, Angelo
; Reichmann, Heinz
and Konitsiotis, Spyridon
(2023)
In Neurodegenerative Diseases
23(1-2).
p.13-19
- Contribution to journal › Scientific review
-
Mark
Comparison of dyskinesia profiles after L-DOPA dose challenges with or without dopamine agonist coadministration
Grigoriou, Sotirios LU
; Espa, Elena
LU
; Odin, Per
LU
; Timpka, Jonathan
LU
; von Grothusen, Gustaf
; Jakobsson, Andreas
LU
and Cenci, M. Angela
LU
(2023)
In Neuropharmacology
237.
- Contribution to journal › Article
-
Mark
The Impact of COVID-19 on Parkinson's Disease : A Case-Controlled Registry and Questionnaire Study on Clinical Markers and Patients' Perceptions
Cedergren Weber, Gustav LU ; Timpka, Jonathan LU ; Bergquist, Filip ; Bäckström, David ; Dizdar, Nil ; Gunnarsson, Karin ; Nyholm, Dag LU ; Svenningsson, Per and Odin, Per LU
(2023)
In Acta Neurologica Scandinavica
2023.
- Contribution to journal › Article
-
Mark
Tumoral parkinsonism—Parkinsonism secondary to brain tumors, paraneoplastic syndromes, intracranial malformations, or oncological intervention, and the effect of dopaminergic treatment
Cedergren Weber, Gustav ; Timpka, Jonathan LU ; Rydelius, Anna LU ; Bengzon, Johan LU and Odin, Per LU
(2023)
In Brain and Behavior
13(8).
- Contribution to journal › Scientific review
- 2022
-
Mark
Does the 5–2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5–2-1-positive patients in 7 countries
Malaty, Irene A. ; Martinez-Martin, Pablo ; Chaudhuri, K. Ray ; Odin, Per LU
; Skorvanek, Matej
; Jimenez-Shahed, Joohi
; Soileau, Michael J.
; Lindvall, Susanna
; Domingos, Josefa
and Jones, Sarah
, et al.
(2022)
In BMC Neurology
22(1).
- Contribution to journal › Article
-
Mark
Objective Observer vs. Patient Motor State Assessments Using the PD Home Diary in Advanced Parkinson's Disease
Timpka, Jonathan LU ; Löhle, Matthias ; Bremer, Alexander ; Christiansson, Sofia ; Gandor, Florin ; Ebersbach, Georg ; Dahlström, Örjan ; Iwarsson, Susanne LU ; Nilsson, Maria H LU
and Storch, Alexander
, et al.
(2022)
In Frontiers in Neurology
13.
- Contribution to journal › Article